Pi‐Hung Tung

Afatinib treatment in a large real‐world cohort of nonsmall cell lung cancer patients with common and uncommon epidermal growth factor receptor mutation

Chi‐Hsien Huang, Jia‐Shiuan Ju, Tzu‐Hsuan Chiu et al. · International Journal of Cancer · 2021 · 20 citations · Full text

First- or second-generation epidermal growth factor receptor tyrosine kinase inhibitors in a large, real-world cohort of patients with non-small cell lung cancer

Allen Chung‐Cheng Huang, Chi‐Hsien Huang, Jia‐Shiuan Ju et al. · Therapeutic Advances in Medical Oncology · 2021 · 19 citations · Full text

The Combination of Afatinib and Bevacizumab in Untreated EGFR-Mutated Advanced Lung Adenocarcinoma: A Multicenter Observational Study

Ping‐Chih Hsu, Chun-Yao Huang, Chin‐Chou Wang et al. · Pharmaceuticals · 2020 · 18 citations · Full text

Brain metastasis, EGFR mutation subtype and generation of EGFR-TKI jointly influence the treatment outcome of patient with EGFR-mutant NSCLC

Jia‐Shiuan Ju, Allen Chung‐Cheng Huang, Pi‐Hung Tung et al. · Scientific Reports · 2023 · 16 citations · Full text

The different overall survival between single-agent EGFR-TKI treatment and with bevacizumab in non-small cell lung cancer patients with brain metastasis

Tzu-Hsuan Chiu, Pi‐Hung Tung, Chi‐Hsien Huang et al. · Scientific Reports · 2022 · 11 citations · Full text